A REVIEW ON SOLID LIPID NANOPARTICLES
Keywords:
Nanoparticles, drug delivery system, Nanostructured lipid carriers, Hot & cold pressure homogenizationAbstract
The Solid lipid nanoparticles were developed in the early 1990s and up today they hfdave been considered as to be promising the drug delivery systems. The aim is to give a sustained release profile to corporated the active substances. The SLN are the submicron colloidal carriers ranging from 50 to 1000 nm it is composed of the physiological lipids dispersed in the water or in liquid surfactant solutions. SLNs combine with the advantages to avoid the drawbacks of several colloidal carriers, Potential disadvantages such as poor drug loading capacity, drug expulsion after polymeric transition during storage and relatively high water content of the dispersions have been observed. The main disadvantages are the limitation of lipid concentration in the organic solvent to form desirable particles and the use of organic solvents. The method is appropriate especially in the encapsulation of thermo sensitive APIs because of the absence of any thermal stress. The Essential oil extracted from Artemisia arboreseens when in corporated in solid lipid nanoparticles were able to reduce the rapid evaporation compared with emulsions and the systems have been used in agriculture as a suitable carrier of ecologically safe pesticides.
Downloads
References
Jumaa M, Muller BW. Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of protective effect. Eur J Pharm Sci 2000;9:285-90.
Cavalli R, Caputo O, Gasco MR. Solid lipospheres of doxorubicin and idarubicin. Int J Pharm 1993;89:R9-R12.
Muller RH, Runge SA. Solid lipid nanoparticles (SLN) for controlled drug delivery, in: S. Benita (Ed.), Sub-micron emulsions in drug targeting and delivery, Amsterdam: Harwood Academic Publishers; 1998, p. 219-34.
Jenning V, Gysler A, Schafer-Korting M, Gohla S. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 2000;49:211-8.
Radtke M, Muller RH. Comparison of structural properties of solid lipid nanoparticles (SLN) versus other lipid particles. Proc Int Symp Control Rel Bioact Mater 2000;27:309-10.
Uner M. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Pharmazie 2006;61:375-86.
Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002; 54:S131-55.
Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004;278:71-7.
Muller RH. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul 2006;23:377-88.
Morel S, Terreno E, Ugazio E, Aime S, Gasco MR. NMR relaxometric investigations of lipid nanoparticles (SLN) containing gadolinium (III) complexes. Eur J Pharm Biopharm 1998;45:157-63.
Battaglia L, Gallarate M, Cavalli R, Trotta M. Solid lipid nanoparticles produced through a coacervation method. Journal of microencapsulation 2010;27(1): 78-85.
Montenegro L, Sarpietro MG, Ottimo S, Puglisi G, Castelli F. Differential scanning calorimetry studies on sunscreen loaded solid lipid nanoparticles prepared by the phase inversion temperature method. Interna-tional journal of pharmaceutics 2011;415(1): 301- 306.
Patel S, Chavhan S, Soni H, Babbar AK, Mathur R, Mishra AK, Sawant K. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route. Journal of Drug Targeting 2011;19(6): 468-474.
Ahlin P, Kristl J, Smid-Korbar J. Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions. Acta pharmaceutica 1998;48(4) 259-267.
Trotta M, Cavalli R, Trotta C, Bussano R, Costa L. Electrospray technique for solid lipid- based particle production. Drug development and industrial pharmacy 2010;36(4): 431- 438.
Charcosset C, El-Harati A, Fessi H. Preparation of solid lipid nanoparticles using a membrane contactor. Journal of controlled release 2005;108(1): 112-120.
Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharmaceutical research 2002;19(6): 875-880.
Carbone C, Tomasello B, Ruozi B, Renis M, Puglisi G. Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. European journal of medicinal chemistry 2012;49: 110-117.
Li Z, Yu L, Zheng L, Geng F. Studies on crystallinity state of puerarin loaded solid lipid nanoparticles prepared by double emulsion method. Journal of thermal analysis and calorimetry 2010;99(2): 689-693.
Varshosaz J, Minayian M, Moazen E. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles. Journal of liposome research 2010;20(2), 115-123.
Lopes R, Eleutério CV, Gonçalves LMD, Cruz MEM., Almeida AJ. Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. European Journal of Pharmaceutical Sciences 2012;45(4): 442-450.
Urbán-Morlán Z, Ganem-Rondero A, Melgoza-Contreras LM, Escobar-Chávez JJ, Nava- Arzaluz MG, Quintanar-Guerrero D. Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method. International journal of nanomedicine 2010;5: 611-620.
Wang T, Wang N, Zhang Y, Shen W, Gao X, Li T. Solvent injection-lyophilization of tert-butyl alcohol/water cosolvent systems for the preparation of drug-loaded solid lipid nanoparticles. Colloids and Surfaces B: Biointerfaces 2010;79(1): 254-261.
Pedersen N, Hansen S, Heydenreich AV, Kristensen HG, Poulsen HS. Solid lipid nanoparticles can effec-tively bind DNA, streptavidin and biotinylated ligands. Eur J Pharm Biopharm 2006;62:155-62.
Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 2007;328:191-5.
Jain SK, Chourasia MK, Masuriha R. Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery. Drug Deliv 2005;12:207-15.
Santos MC, Mehnert W, Schaller M. Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 2002;10:489-95.
Wissing SA, Muller RH. Solid lipid nanoparticles a novel carrier for UV blockers. Pharmazie 2001;56:783-6.
Mei Z, Wu Q. Triptolide loaded solid lipid nanoparticle hydrogel for topical application. Drug Develop Ind Pharm 2005;31:161-8.
Wissing S, Lippacher A, Muller R. Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J Cosmet Sci 2001;52:313-24. 47.
Jenning V, Gysler A, Schafer-Korting M, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 2000;49:211-8.
Murthy RSR. Solid lipid nanoparticles as carriers for anti-cancer drugs to solid tumours. Drug Deliv 2005;12:385-92.
Ruckmani K, Sivakumar M, Ganeshkumar PA. Methotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinoma. J Nanosci Nanotechnol 2006;6:2991-5. 24
Lu B, Xiong SB, Yang H., Yin XD, Chao RB. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymphnode metastases. Eur J Pharm Sci 2006;28:86-95.
Wang Y, Wu W. In situ evading of phagocytic uptake of stealth solid lipid nanoparticles by mouse peritoneal macrophages. Drug Deliv 2006;13:189-92.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
